1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA KIF18B CTRPv2 pan-cancer AAC -0.093 0.01
mRNA ADRB1 CTRPv2 pan-cancer AAC 0.095 0.01
mRNA ADORA2A CTRPv2 pan-cancer AAC -0.098 0.01
mRNA WDR81 CTRPv2 pan-cancer AAC 0.095 0.01
mRNA ADCK5 CTRPv2 pan-cancer AAC 0.094 0.01
mRNA PSAT1 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA KIF20A CTRPv2 pan-cancer AAC -0.097 0.01
mRNA PROM2 CTRPv2 pan-cancer AAC 0.11 0.01
mRNA ARHGEF25 CTRPv2 pan-cancer AAC -0.096 0.01
mRNA EEF1E1-BLOC1S5 CTRPv2 pan-cancer AAC -0.093 0.01
Download CSV